Novo Integrated Sciences 任命 Robert Oliva 为总裁，以提高运营效率并推动基于产品的业务部门的增长。 Novo Integrated Sciences appoints Robert Oliva as President to enhance operational efficiency and drive growth in product-based business units.
Novo Integrated Sciences (NVOS) 任命 Robert Oliva 为新任总裁，接替 Christopher David，后者继续担任首席运营官和董事会成员。 Novo Integrated Sciences (NVOS) has named Robert Oliva as their new President, taking over from Christopher David who continues as COO and Board of Directors member. Oliva 在业务开发和制造运营方面拥有超过 35 年的经验，预计将提高公司的运营效率并管理可持续增长。 With over 35 years of experience in business development and manufacturing operations, Oliva is expected to improve the company's operational efficiency and manage sustainable growth. 首席执行官 Robert Mattacchione 赞扬了 Oliva 的经验，表示这将有助于加速公司基于产品的业务部门的增长。 CEO Robert Mattacchione praised Oliva's experience, stating it will aid in accelerating growth in the company's product-based business unit. Novo Integrated Sciences 致力于通过结合医疗技术、先进疗法和康复科学的多学科生态系统，以患者为先的医疗保健方法。 Novo Integrated Sciences focuses on a patient-first approach to healthcare through a multidisciplinary ecosystem combining medical technology, advanced therapeutics, and rehabilitative science.